Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • rory
    Member
    • Aug 2008
    • 28

    ChIPQC: a package for assessing quality of ChIP-seq samples and experiments

    In conjunction with my colleague, Thomas Carroll, who has been looking at quality metrics for ChIP-seq libraries on a large scale (including evaluating more than 400 ENCODE libraries), we have developed ChIPQC, which is included in this week's Bioconductor 2.14 release.

    ChIPQC offers a straightforward way to generate an interactive QC report for a sample or a set of samples associated with an experiment.
    You can check out a report for an example experiment with 11 samples and 5 controls (or a PDF image of this report.)

    When ChIPQC is supplied with one or more .bam files, it computes a number of metrics relating to the alignments, including duplication rates, mapping quality filtering rates, distribution of pileups (and the associated SSD measure), and an estimated fragment size based on maximizing a relative cross-coverage score. Specifying a genome annotation (human, mouse, rat, fly, and worm are directly supported) enables calculation of genomic profiles, showing enrichment and depletion at various genomic features. Blacklists can also be used for filtering. Finally, supplying one or more sets of peaks enables computation of enrichment of reads in peaks, mean binding profiles around peaks, and clustering/PCA plots of how samples in an experiment are correlated based on peak signals.

    The package uses BiocParallel for parallelization, and analyses may be limited to a specific subsets of the chromosomes for faster processing.
    The package vignette includes several examples with code included.

    For those who may already be using the DiffBind package, these two packages work hand-in-hand, using the same samplesheets. If you already have an experiment loaded in DiffBind, you may pass the DBA object directly to ChIPQC and generate a report in two steps, eg:

    > expQC = ChIPQC(DBA, annotation="hg19")
    > ChIPQCreport(expQC)

    One you have a ChIPQCexperiment object, you may use this in DiffBind to analyze peak overlaps and perform differential binding analysis automatically using the edgeR and/or DESeq2 packages, eg:

    > result = dba.analyze(expQC, method=c(DBA_EDGER,DBA_DESEQ2))

    This initial release of ChIPQC includes a baseline of functionality, with a focus on making it easy to generate a fairly comprehensive report quickly. Tom and I intend to continue to develop and support this package so long as there is interest, so please do report any issues you may have, and forward suggestions of what you think would be useful in a ChIP-seq quality assessment package.

    Thanks-
    Rory
  • crazyhottommy
    Senior Member
    • Apr 2012
    • 187

    #2
    Looks very promising, thank you.

    Comment

    • natallah
      Junior Member
      • Mar 2012
      • 7

      #3
      I am trying to use ChIPQC with the ensembl GrCh38 build of the human genome. Us ChIPQC not compatible with the ENSEMBL genome builds?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      213 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      79 views
      0 reactions
      Last Post SEQadmin2  
      Working...